Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology
0 sources
Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology
Summary
Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology is a written work[1].
Key Facts
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology authored Joshua A Roth[2].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's instance of is recorded as written work[3].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's instance of is recorded as doctoral thesis[4].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's OCLC number is recorded as 891111151[5].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's language of work or name is recorded as English[6].
- +2012-00-00T00:00:00Z marks the founding of Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology[7].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's work available at URL is recorded as http://hdl.handle.net/1773/22617[8].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's Handle ID is recorded as 1773/22617[9].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's title is recorded as Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology[10].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's thesis submitted to is recorded as University of Washington[11].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's on focus list of Wikimedia project is recorded as WikiProject PCC Wikidata Pilot/University of Washington[12].
- Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology's thesis committee member is recorded as David L Veenstra[13].
Body
Designation and Status
Recorded instance of include written work[3] and doctoral thesis[4].
History and Context
+2012-00-00T00:00:00Z marks the founding of Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology[7].